Internal Medicine, Medical Oncology · San Diego, CA
NPI
1437196433
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
200 W Arbor Dr
San Diego, CA, 92103
Phone (800) 926-8273
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
267 services
Medicare patients, 2024
59
Average age 71
Drug cost, 2024
$639K
335 prescriptions
Company payments, 2025
$2,538
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bassel F El-Rayes was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 101 times for 43 patients. In total Bassel F El-Rayes billed 267 services in 9 codes, and Medicare paid $15K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 101 | 43 | $12.09 | $1,221 |
| 99214 Office E&M - Established | Facility | 74 | 41 | $59.19 | $4,380 |
| 99215 Office E&M - Established | Facility | 73 | 33 | $105.17 | $7,677 |
By year: 2022 $6,818 for 94 services; 2023 $15K for 210 services; 2024 $15K for 267 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bassel F El-Rayes prescribed most often to Medicare patients was Oxycodone Hcl, with 33 prescriptions and refills. In total Bassel F El-Rayes wrote 335 Medicare prescriptions that cost $639K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 33 | 33 | Under 11 | $796 |
| Morphine Sulfate Er Morphine Sulfate | 18 | 18 | Under 11 | $373 |
| Gabapentin Generic | 16 | 16 | Under 11 | $133 |
| Amlodipine Besylate Generic | 16 | 22 | Under 11 | $83.04 |
| Lorazepam Generic | 15 | 15 | Under 11 | $57.48 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 15 | 15 | Under 11 | $272 |
| Lonsurf Trifluridine/Tipiracil Hcl | 14 | 14 | Under 11 | $172K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 14 | 14 | Under 11 | $170 |
| Afinitor Everolimus | 13 | 13 | Under 11 | $227K |
| Promethazine Hcl Generic | 11 | 11 | Under 11 | $356 |
| Methocarbamol Generic | 11 | 11 | Under 11 | $80.04 |
Brand drugs: 77 claims; generic drugs: 258 claims; opioid claims: 82.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bassel F El-Rayes $2,538 ($2,538 in general payments such as food, travel and fees) from 3 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $2,538.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $2,538 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.